Neil Chatterji
Stock Analyst at B. Riley Securities
(1.09)
# 3,703
Out of 4,915 analysts
19
Total ratings
23.53%
Success rate
-0.35%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $10.40 | +169.23% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $12.62 | +3.01% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $41.96 | +19.18% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.31 | +472.52% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $13.71 | +31.29% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.47 | +29.68% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.06 | +230.19% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.27 | +142.29% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $1.71 | +455.56% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $10.40
Upside: +169.23%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $12.62
Upside: +3.01%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $41.96
Upside: +19.18%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.31
Upside: +472.52%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $13.71
Upside: +31.29%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.47
Upside: +29.68%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.06
Upside: +230.19%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.27
Upside: +142.29%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $1.71
Upside: +455.56%